Image Source: Startup Story
Safex Chemicals Ltd, backed by private equity giant ChrysCapital, has filed draft papers with SEBI to launch its initial public offering (IPO), aiming to raise ₹450 crore via a fresh issue, alongside an offer-for-sale (OFS) of 3.57 crore shares by existing shareholders. The Delhi-based agrochemical firm plans to use ₹365.6 crore from the proceeds to repay outstanding debt, with the remainder allocated for general corporate purposes.
Promoters currently hold 54.3%, while ChrysCapital—through entities like Sarcoline, Anchor Partners, and Sage Investment Trust—owns 44.8%. The company may also raise up to ₹90 crore in a pre-IPO round.
Safex operates across three verticals: branded formulations, specialty chemicals, and contract development & manufacturing (CDMO), with a UK-based plant in Norwich. Despite posting a loss of ₹14.3 crore in FY25, revenue rose 12.8% YoY to ₹1,584.8 crore. The IPO is being managed by Axis Capital, JM Financial, and SBI Capital Markets.
Key Highlights:
-
Fresh Issue: ₹450 crore
-
OFS: 3.57 crore shares
-
Use of Funds: ₹365.6 crore for debt repayment
-
FY25 Revenue: ₹1,584.8 crore (+12.8% YoY)
-
FY25 Loss: ₹14.3 crore (vs ₹22.8 crore in FY24)
-
Pre-IPO Round: Up to ₹90 crore under consideration
Source: Moneycontrol – Safex Chemicals IPO Filing Details
Advertisement
Advertisement